LNC Therapeutics becomes YSOPIA Bioscience marking its transition to a clinical stage company
Sep 29, 2020
more +LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial...
Sep 8, 2020
more +LNC Therapeutics announces the acquisition of an exclusive worldwide license on the first patent...
Apr 15, 2020
more +LNC Therapeutics Announces Successful GMP Manufacturing of Xla1 for Phase 1 Clinical Trial
Mar 12, 2020
more +LNC Therapeutics and the National Institute for Agricultural Research (INRA) sign research...
Dec 11, 2019
more +